ArticleCancer medicine2021

Determining the optimal PD-1/PD-L1 inhibitors for the first-line treatment of non-small-cell lung cancer with high-level PD-L1 expression in China.

Meng-Meng Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.